RTTNews | Sep 21, 2020 10:26AM EDT

10:26 Monday, September 21, 2020 (RTTNews) - Seattle, Genmab Present Data From Tisotumab Vedotin InnovaTV 204 Trial In Recurrent Or Metastatic Cervical Cancer

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved